SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model. Kai Fu,Michael J Corbley,Lihong Sun,Jessica E Friedman,Feng Shan,James L Papadatos,Donald Costa,Frank Lutterodt,Harry Sweigard,Scott Bowes,Michael Choi,P Ann Boriack-Sjodin,Robert M Arduini,Dongyu Sun,Miki N Newman,Xiamei Zhang,Jonathan N Mead,Claudio E Chuaqui,H-Kam Cheung,Xin Zhang,Mark Cornebise,Mary Beth Carter,Serene Josiah,Juswinder Singh,Wen-Cherng Lee,Alan Gill,Leona E Ling Arteriosclerosis, thrombosis, and vascular biology
28
2008
Show Abstract
TGF-beta plays a significant role in vascular injury-induced stenosis. This study evaluates the efficacy of a novel, small molecule inhibitor of ALK5/ALK4 kinase, in the rat carotid injury model of vascular fibrosis. | 18202322
 |